Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2013

01.09.2013 | Colorectal Cancer

Multivisceral Resection in Colorectal Cancer: A Systematic Review

verfasst von: H. M. Mohan, MRCSI, M. D. Evans, BM, MPhil, FRCS, J. O. Larkin, PhD, FRCS, J. Beynon, MS, D. C. Winter, MD, FRCS

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

The objective of this study was to critically evaluate current literature on outcomes following multivisceral resection (MVR) in colorectal cancer (CRC). Adequate surgical resection with clear margins is imperative in achieving long-term survival in colorectal cancer. Where there is adherence to or invasion of adjacent organs, (MVR) may be needed to achieve complete disease clearance.

Methods

A systematic review of MVR in CRC was performed. Pubmed/Medline and Cochrane databases were searched for English language articles from 1995 to 2012 using a predefined strategy. Retrieved abstracts were independently screened for relevance and data extracted from selected studies by 2 researchers. Results are reported as weighted means.

Results

Included were 22 studies comprising 1575 patients (87.0 % primary colorectal cancer; 13.0 % recurrent, 63.8 % rectal; 36.2 % colon). The most common organs resected were the bladder and reproductive organs. The perioperative mortality was 4.2 % with morbidity of 41.5 % (95 % CI, 40.8–42.2 %). The overall 5-year survival rate was 50.3 % (95 % CI, 49.9–50.8 %). Surgery for recurrence was associated with worse outcomes than primary tumors with 5-year survival 19.5 % (95 % CI, 17.8–21.1 %) for recurrent rectal cancer and primary rectal tumors 5-year overall survival 52.8 % (95 % CI, 52.0–53.8 %). R0 resection was the strongest factor associated with long-term survival.

Conclusions

Multivisceral resection provides the best possibility of long-term survival in locally advanced primary colorectal cancer in which a clear margin has been achieved.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat How P, Shihab O, Tekkis P, Brown G, Quirke P, Heald R, et al. A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol. 2011;20:e149–55.PubMedCrossRef How P, Shihab O, Tekkis P, Brown G, Quirke P, Heald R, et al. A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol. 2011;20:e149–55.PubMedCrossRef
2.
Zurück zum Zitat Davies M, Harris D, Hirst G, Beynon R, Morgan AR, Carr ND, et al. Local recurrence after abdomino-perineal resection. Colorectal Dis. 2009;11:39–43.PubMedCrossRef Davies M, Harris D, Hirst G, Beynon R, Morgan AR, Carr ND, et al. Local recurrence after abdomino-perineal resection. Colorectal Dis. 2009;11:39–43.PubMedCrossRef
3.
Zurück zum Zitat Nielsen MB, Laurberg S, Holm T. Current management of locally recurrent rectal cancer. Colorectal Dis. 2011;13:732–42.PubMedCrossRef Nielsen MB, Laurberg S, Holm T. Current management of locally recurrent rectal cancer. Colorectal Dis. 2011;13:732–42.PubMedCrossRef
4.
Zurück zum Zitat Hida J, Yasutomi M, Maruyama T, Nakajima A, Uchida T, Wakano T, et al. Results from pelvic exenteration for locally advanced colorectal cancer with lymph node metastases. Dis Colon Rectum. 1998;41:165–8.PubMedCrossRef Hida J, Yasutomi M, Maruyama T, Nakajima A, Uchida T, Wakano T, et al. Results from pelvic exenteration for locally advanced colorectal cancer with lymph node metastases. Dis Colon Rectum. 1998;41:165–8.PubMedCrossRef
5.
Zurück zum Zitat Gebhardt C, Meyer W, Ruckriegel S, Meier U. Multivisceral resection of advanced colorectal carcinoma. Langenbecks Arch Surg. 1999;384:194–9.PubMedCrossRef Gebhardt C, Meyer W, Ruckriegel S, Meier U. Multivisceral resection of advanced colorectal carcinoma. Langenbecks Arch Surg. 1999;384:194–9.PubMedCrossRef
6.
Zurück zum Zitat Davies ML, Harris D, Davies M, Lucas M, Drew P, Beynon J. Selection criteria for the radical treatment of locally advanced rectal cancer. Int J Surg Oncol. 2011;2011:678506.PubMed Davies ML, Harris D, Davies M, Lucas M, Drew P, Beynon J. Selection criteria for the radical treatment of locally advanced rectal cancer. Int J Surg Oncol. 2011;2011:678506.PubMed
7.
Zurück zum Zitat Sugarbaker ED. Coincident removal of additional structures in resections for carcinoma of the colon and rectum. Ann Surg. 1946;123:1036–46.CrossRef Sugarbaker ED. Coincident removal of additional structures in resections for carcinoma of the colon and rectum. Ann Surg. 1946;123:1036–46.CrossRef
8.
Zurück zum Zitat Chen YG, Liu YL, Jiang SX, Wang XS. Adhesion pattern and prognosis studies of T4N0M0 colorectal cancer following en bloc multivisceral resection: evaluation of T4 subclassification. Cell Biochem Biophys. 2011;59:1–6.PubMedCrossRef Chen YG, Liu YL, Jiang SX, Wang XS. Adhesion pattern and prognosis studies of T4N0M0 colorectal cancer following en bloc multivisceral resection: evaluation of T4 subclassification. Cell Biochem Biophys. 2011;59:1–6.PubMedCrossRef
9.
Zurück zum Zitat Bartos A, Bartos D, Dunca F, Mocanu L, Zaharie F, Iancu M, et al. Multi-organ resections for colorectal cancer: analysis of potential factors with role in the occurrence of postoperative complications and deaths. Chirurgia (Bucur). 2012;107:476–82.PubMed Bartos A, Bartos D, Dunca F, Mocanu L, Zaharie F, Iancu M, et al. Multi-organ resections for colorectal cancer: analysis of potential factors with role in the occurrence of postoperative complications and deaths. Chirurgia (Bucur). 2012;107:476–82.PubMed
10.
Zurück zum Zitat Govindarajan A, Coburn NG, Kiss A, Rabeneck L, Smith AJ, Law CH. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst. 2006;98:1474–81.PubMedCrossRef Govindarajan A, Coburn NG, Kiss A, Rabeneck L, Smith AJ, Law CH. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst. 2006;98:1474–81.PubMedCrossRef
11.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.PubMedCrossRef Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.PubMedCrossRef
12.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.PubMedCrossRef Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.PubMedCrossRef
13.
Zurück zum Zitat Borowski DW, Bradburn DM, Mills SJ, Bharathan B, Wilson RG, Ratcliffe AA, et al. Volume-outcome analysis of colorectal cancer-related outcomes. Br J Surg. 2010;97:1416–30.PubMedCrossRef Borowski DW, Bradburn DM, Mills SJ, Bharathan B, Wilson RG, Ratcliffe AA, et al. Volume-outcome analysis of colorectal cancer-related outcomes. Br J Surg. 2010;97:1416–30.PubMedCrossRef
14.
Zurück zum Zitat Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377–84.PubMedCrossRef Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377–84.PubMedCrossRef
15.
Zurück zum Zitat Nielsen M, Rasmussen P, Lindegaard J, Laurberg S. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Colorectal Dis. 2012;14:1076–83.PubMedCrossRef Nielsen M, Rasmussen P, Lindegaard J, Laurberg S. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Colorectal Dis. 2012;14:1076–83.PubMedCrossRef
16.
Zurück zum Zitat Saito N, Suzuki T, Tanaka T, Sugito M, Ito M, Kobayashi A, et al. Preliminary experience with bladder preservation for lower rectal cancers involving the lower urinary tract. J Surg Oncol. 2010;102:778–83.PubMedCrossRef Saito N, Suzuki T, Tanaka T, Sugito M, Ito M, Kobayashi A, et al. Preliminary experience with bladder preservation for lower rectal cancers involving the lower urinary tract. J Surg Oncol. 2010;102:778–83.PubMedCrossRef
17.
Zurück zum Zitat Oledzki J, Chwalinski M, Rogowski W, Sopylo R, Nowacki MP. Total cystectomies in the surgical treatment of rectal cancer with prior chemoradiation: analysis of postoperative morbidity and survival. Int J Colorectal Dis. 2004;19:124–7.PubMedCrossRef Oledzki J, Chwalinski M, Rogowski W, Sopylo R, Nowacki MP. Total cystectomies in the surgical treatment of rectal cancer with prior chemoradiation: analysis of postoperative morbidity and survival. Int J Colorectal Dis. 2004;19:124–7.PubMedCrossRef
18.
Zurück zum Zitat Bannura GC, Barrera AE, Cumsille MA, Contreras JP, Melo CL, Soto DC, et al. Posterior pelvic exenteration for primary rectal cancer. Colorectal Dis. 2006;8:309–13.PubMedCrossRef Bannura GC, Barrera AE, Cumsille MA, Contreras JP, Melo CL, Soto DC, et al. Posterior pelvic exenteration for primary rectal cancer. Colorectal Dis. 2006;8:309–13.PubMedCrossRef
19.
Zurück zum Zitat Park S, Lee YS. Analysis of the prognostic effectiveness of a multivisceral resection for locally advanced colorectal cancer. J Korean Soc Coloproctol. 2011;27:21–6.PubMedCrossRef Park S, Lee YS. Analysis of the prognostic effectiveness of a multivisceral resection for locally advanced colorectal cancer. J Korean Soc Coloproctol. 2011;27:21–6.PubMedCrossRef
20.
Zurück zum Zitat Nakafusa Y, Tanaka T, Tanaka M, Kitajima Y, Sato S, Miyazaki K. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum. 2004;47:2055–63.PubMedCrossRef Nakafusa Y, Tanaka T, Tanaka M, Kitajima Y, Sato S, Miyazaki K. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum. 2004;47:2055–63.PubMedCrossRef
21.
Zurück zum Zitat Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S. Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum. 2003;46:474–80.PubMedCrossRef Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S. Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum. 2003;46:474–80.PubMedCrossRef
22.
Zurück zum Zitat Ike H, Shimada H, Ohki S, Yamaguchi S, Ichikawa Y, Fujii S. Outcome of total pelvic exenteration for locally recurrent rectal cancer. Hepatogastroenterology. 2003;50:700–3.PubMed Ike H, Shimada H, Ohki S, Yamaguchi S, Ichikawa Y, Fujii S. Outcome of total pelvic exenteration for locally recurrent rectal cancer. Hepatogastroenterology. 2003;50:700–3.PubMed
23.
Zurück zum Zitat Harris DA, Davies M, Lucas MG, Drew P, Carr ND, Beynon J. Multivisceral resection for primary locally advanced rectal carcinoma. Br J Surg. 2011;98:582–8.PubMedCrossRef Harris DA, Davies M, Lucas MG, Drew P, Carr ND, Beynon J. Multivisceral resection for primary locally advanced rectal carcinoma. Br J Surg. 2011;98:582–8.PubMedCrossRef
24.
Zurück zum Zitat McNamara DA, Fitzpatrick JM, O’Connell PR. Urinary tract involvement by colorectal cancer. Dis Colon Rectum. 2003;46:1266–76.PubMedCrossRef McNamara DA, Fitzpatrick JM, O’Connell PR. Urinary tract involvement by colorectal cancer. Dis Colon Rectum. 2003;46:1266–76.PubMedCrossRef
25.
Zurück zum Zitat Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235:217–25.PubMedCrossRef Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235:217–25.PubMedCrossRef
26.
Zurück zum Zitat Vermaas M, Ferenschild FT, Verhoef C, Nuyttens JJ, Marinelli AW, Wiggers T, et al. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol. 2007;33:452–8.PubMedCrossRef Vermaas M, Ferenschild FT, Verhoef C, Nuyttens JJ, Marinelli AW, Wiggers T, et al. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol. 2007;33:452–8.PubMedCrossRef
27.
Zurück zum Zitat Lopez-Cano M, Manas MJ, Hermosilla E, Espin E. Multivisceral resection for colon cancer: analysis of prognostic factors. Dig Surg. 2010;27:238–45.PubMedCrossRef Lopez-Cano M, Manas MJ, Hermosilla E, Espin E. Multivisceral resection for colon cancer: analysis of prognostic factors. Dig Surg. 2010;27:238–45.PubMedCrossRef
28.
Zurück zum Zitat Jimenez RE, Shoup M, Cohen AM, Paty PB, Guillem J, Wong WD. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Dis Colon Rectum. 2003;46:1619–25.PubMedCrossRef Jimenez RE, Shoup M, Cohen AM, Paty PB, Guillem J, Wong WD. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Dis Colon Rectum. 2003;46:1619–25.PubMedCrossRef
29.
Zurück zum Zitat Ike H, Shimada H, Fujii S, Kamimukai N, Ohshima T, Imada T. Extended abdominoperineal resection with partial prostatectomy for T3 rectal cancer. Hepatogastroenterology. 2003;50:377–9.PubMed Ike H, Shimada H, Fujii S, Kamimukai N, Ohshima T, Imada T. Extended abdominoperineal resection with partial prostatectomy for T3 rectal cancer. Hepatogastroenterology. 2003;50:377–9.PubMed
30.
Zurück zum Zitat Cukier M, Smith AJ, Milot L, Chu W, Chung H, Fenech D, et al. Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: A single institution experience. Eur J Surg Oncol. 2012;38:677–82.PubMedCrossRef Cukier M, Smith AJ, Milot L, Chu W, Chung H, Fenech D, et al. Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: A single institution experience. Eur J Surg Oncol. 2012;38:677–82.PubMedCrossRef
31.
Zurück zum Zitat Luna-Perez P, Rodriguez-Ramirez SE, De la Barrera MG, Zeferino M, Labastida S. Multivisceral resection for colon cancer. J Surg Oncol. 2002;80:100–4.PubMedCrossRef Luna-Perez P, Rodriguez-Ramirez SE, De la Barrera MG, Zeferino M, Labastida S. Multivisceral resection for colon cancer. J Surg Oncol. 2002;80:100–4.PubMedCrossRef
32.
Zurück zum Zitat Winter DC, Walsh R, Lee G, Kiely D, O’Riordain MG, O’Sullivan GC. Local involvement of the urinary bladder in primary colorectal cancer: outcome with en-bloc resection. Ann Surg Oncol. 2007;14:69–73.PubMedCrossRef Winter DC, Walsh R, Lee G, Kiely D, O’Riordain MG, O’Sullivan GC. Local involvement of the urinary bladder in primary colorectal cancer: outcome with en-bloc resection. Ann Surg Oncol. 2007;14:69–73.PubMedCrossRef
33.
Zurück zum Zitat Gezen C, Kement M, Altuntas YE, Okkabaz N, Seker M, Vural S, et al. Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors. World J Surg Oncol. 2012;10:39.PubMedCrossRef Gezen C, Kement M, Altuntas YE, Okkabaz N, Seker M, Vural S, et al. Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors. World J Surg Oncol. 2012;10:39.PubMedCrossRef
34.
Zurück zum Zitat Li JC, Chong CC, Ng SS, Yiu RY, Lee JF, Leung KL. En bloc urinary bladder resection for locally advanced colorectal cancer: a 17-year experience. Int J Colorectal Dis. 2011;26:1169–76.PubMedCrossRef Li JC, Chong CC, Ng SS, Yiu RY, Lee JF, Leung KL. En bloc urinary bladder resection for locally advanced colorectal cancer: a 17-year experience. Int J Colorectal Dis. 2011;26:1169–76.PubMedCrossRef
35.
Zurück zum Zitat Hoffmann M, Phillips C, Oevermann E, Killaitis C, Roblick UJ, Hildebrand P, et al. Multivisceral and standard resections in colorectal cancer. Langenbecks Arch Surg. 2012;397:75–84.PubMedCrossRef Hoffmann M, Phillips C, Oevermann E, Killaitis C, Roblick UJ, Hildebrand P, et al. Multivisceral and standard resections in colorectal cancer. Langenbecks Arch Surg. 2012;397:75–84.PubMedCrossRef
36.
Zurück zum Zitat Derici H, Unalp HR, Kamer E, Bozdag AD, Tansug T, Nazli O, et al. Multivisceral resections for locally advanced rectal cancer. Colorectal Dis. 2008;10:453–9.PubMedCrossRef Derici H, Unalp HR, Kamer E, Bozdag AD, Tansug T, Nazli O, et al. Multivisceral resections for locally advanced rectal cancer. Colorectal Dis. 2008;10:453–9.PubMedCrossRef
37.
Zurück zum Zitat Smith JD, Nash GM, Weiser MR, Temple LK, Guillem JG, Paty PB. Multivisceral resection for rectal cancer Br J Surg. 2012;99:1137–43. Smith JD, Nash GM, Weiser MR, Temple LK, Guillem JG, Paty PB. Multivisceral resection for rectal cancer Br J Surg. 2012;99:1137–43.
38.
Zurück zum Zitat Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum. 2002;45:1078–84.PubMedCrossRef Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum. 2002;45:1078–84.PubMedCrossRef
39.
Zurück zum Zitat Zoucas E, Frederiksen S, Lydrup ML, Mansson W, Gustafson P, Alberius P. Pelvic exenteration for advanced and recurrent malignancy. World J Surg. 2010;34:2177–84.PubMedCrossRef Zoucas E, Frederiksen S, Lydrup ML, Mansson W, Gustafson P, Alberius P. Pelvic exenteration for advanced and recurrent malignancy. World J Surg. 2010;34:2177–84.PubMedCrossRef
40.
Zurück zum Zitat Hunter JA, Ryan JA, Jr., Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg. 1987;154:67–71.PubMedCrossRef Hunter JA, Ryan JA, Jr., Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg. 1987;154:67–71.PubMedCrossRef
41.
Zurück zum Zitat Law WL, Chu KW, Choi HK. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg. 2000;190:78–83.PubMedCrossRef Law WL, Chu KW, Choi HK. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg. 2000;190:78–83.PubMedCrossRef
42.
Zurück zum Zitat Shirouzu K, Isomoto H, Kakegawa T. Total pelvic exenteration for locally advanced colorectal carcinoma. Br J Surg. 1996;83:32–5.PubMedCrossRef Shirouzu K, Isomoto H, Kakegawa T. Total pelvic exenteration for locally advanced colorectal carcinoma. Br J Surg. 1996;83:32–5.PubMedCrossRef
43.
Zurück zum Zitat Poeze M, Houbiers JG, van de Velde CJ, Wobbes T, von Meyenfeldt MF. Radical resection of locally advanced colorectal cancer. Br J Surg. 1995;82:1386–90.PubMedCrossRef Poeze M, Houbiers JG, van de Velde CJ, Wobbes T, von Meyenfeldt MF. Radical resection of locally advanced colorectal cancer. Br J Surg. 1995;82:1386–90.PubMedCrossRef
44.
Zurück zum Zitat Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99:918–28.PubMedCrossRef Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99:918–28.PubMedCrossRef
45.
Zurück zum Zitat Smith FM, Chang KH, Sheahan K, Hyland J, O’Connell PR, Winter DC. The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy. Br J Surg. 2012;99:993–1001.PubMedCrossRef Smith FM, Chang KH, Sheahan K, Hyland J, O’Connell PR, Winter DC. The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy. Br J Surg. 2012;99:993–1001.PubMedCrossRef
46.
Zurück zum Zitat Tekkis PP, Poloniecki JD, Thompson MR, Stamatakis JD. Operative mortality in colorectal cancer: prospective national study. BMJ. 2003;327:1196–201.PubMedCrossRef Tekkis PP, Poloniecki JD, Thompson MR, Stamatakis JD. Operative mortality in colorectal cancer: prospective national study. BMJ. 2003;327:1196–201.PubMedCrossRef
47.
Zurück zum Zitat Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010;251:807–18.PubMedCrossRef Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010;251:807–18.PubMedCrossRef
48.
Zurück zum Zitat Gannon CJ, Zager JS, Chang GJ, Feig BW, Wood CG, Skibber JM, et al. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007;14:1870–7.PubMedCrossRef Gannon CJ, Zager JS, Chang GJ, Feig BW, Wood CG, Skibber JM, et al. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007;14:1870–7.PubMedCrossRef
49.
Zurück zum Zitat Ishiguro S, Akasu T, Fujita S, Yamamoto S, Kusters M, Moriya Y. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period. Surgery. 2009;145:189–95.PubMedCrossRef Ishiguro S, Akasu T, Fujita S, Yamamoto S, Kusters M, Moriya Y. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period. Surgery. 2009;145:189–95.PubMedCrossRef
Metadaten
Titel
Multivisceral Resection in Colorectal Cancer: A Systematic Review
verfasst von
H. M. Mohan, MRCSI
M. D. Evans, BM, MPhil, FRCS
J. O. Larkin, PhD, FRCS
J. Beynon, MS
D. C. Winter, MD, FRCS
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2013
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-2967-9

Weitere Artikel der Ausgabe 9/2013

Annals of Surgical Oncology 9/2013 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.